MODD vs. QIPT, TELA, BWAY, KRMD, BLUA, HSAQ, SRTS, PDEX, MGRM, and NVNO
Should you be buying Modular Medical stock or one of its competitors? The main competitors of Modular Medical include Quipt Home Medical (QIPT), TELA Bio (TELA), BrainsWay (BWAY), KORU Medical Systems (KRMD), BlueRiver Acquisition (BLUA), Health Sciences Acquisitions Co. 2 (HSAQ), Sensus Healthcare (SRTS), Pro-Dex (PDEX), Monogram Orthopaedics (MGRM), and enVVeno Medical (NVNO). These companies are all part of the "surgical & medical instruments" industry.
Modular Medical (NASDAQ:MODD) and Quipt Home Medical (NASDAQ:QIPT) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, community ranking, institutional ownership, valuation, profitability, analyst recommendations, earnings, media sentiment and risk.
Modular Medical presently has a consensus target price of $4.25, suggesting a potential upside of 151.48%. Quipt Home Medical has a consensus target price of $7.25, suggesting a potential upside of 121.71%. Given Modular Medical's stronger consensus rating and higher possible upside, equities research analysts plainly believe Modular Medical is more favorable than Quipt Home Medical.
In the previous week, Modular Medical and Modular Medical both had 1 articles in the media. Modular Medical's average media sentiment score of 1.89 beat Quipt Home Medical's score of 1.87 indicating that Modular Medical is being referred to more favorably in the media.
27.5% of Modular Medical shares are held by institutional investors. Comparatively, 42.9% of Quipt Home Medical shares are held by institutional investors. 32.3% of Modular Medical shares are held by insiders. Comparatively, 4.2% of Quipt Home Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Quipt Home Medical has higher revenue and earnings than Modular Medical. Quipt Home Medical is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.
Modular Medical has a beta of 0.52, meaning that its share price is 48% less volatile than the S&P 500. Comparatively, Quipt Home Medical has a beta of 0.64, meaning that its share price is 36% less volatile than the S&P 500.
Quipt Home Medical received 26 more outperform votes than Modular Medical when rated by MarketBeat users. However, 100.00% of users gave Modular Medical an outperform vote while only 82.35% of users gave Quipt Home Medical an outperform vote.
Modular Medical has a net margin of 0.00% compared to Quipt Home Medical's net margin of -1.71%. Quipt Home Medical's return on equity of -3.89% beat Modular Medical's return on equity.
Summary
Quipt Home Medical beats Modular Medical on 10 of the 17 factors compared between the two stocks.
Get Modular Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for MODD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MODD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Modular Medical Competitors List
Related Companies and Tools
